Agfa-gevaert Nv · EURONEXT:AGFB
Agfa-gevaert Nv — Q3 2019 Earnings Presentation
26 slides from Agfa-gevaert Nv's earnings presentation, Nov 6, 2019
Slide 1: Q3 2019 Results
Q3 2019 Results Agfa-Gevaert Group November 6, 2019
Slide 2: Transformation process
Transformation process Milestones The implementation of the offset alliance with Lucky HuaGuang Graphics is running as expected. We continued to expand the common sales platform into more regions within China. In the third quarter, we launched the auction process for the sale of part of the IT a
Slide 3: Sales by division 9m 2019
Agfa-Gevaert Group Sales by division 9m 2019 = 1,668 million Euro 18% 37% Offset Solutions Radiology Solutions 22% HealthCare IT Digital Print and Chemicals 23% 3
Slide 4: Agfa-Gevaert Group key figures
Agfa-Gevaert Group Q3 ’19 Q3 ’18 ∆% 9m’19 9m’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 553 539 2.6% 1668 1647 1.3% (1.1%) (-0.2%) Gross Profit* 171 171 -0.1% 542 529 2.3% as a %
Slide 5: Agfa-Gevaert Group profit and loss
Agfa-Gevaert Group Q3 ’19 Q3 ’18 ∆% 9m’19 9m’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl. IFRS 16) (excl. IFRS 16, in million Euro restated) restated) Profit & Loss Adjusted EBIT* 24** 21 11.1% 85 81 4.6% Restructuring/non- -7 -15 -22 -28 recurring Operating result 17 6 172.8% 63 52 19.6
Slide 6: Main drivers behind key figures
Agfa-Gevaert Group Continuing the positive evolution of the first half of the year, the Agfa-Gevaert Group’s top line grew by 2.6% (1.1% Main drivers behind excluding exchange rate effects) in the third quarter of 2019. key figures Most growth engines, as well as the hardcopy product line, contrib
Slide 7: Net financial debt
Agfa-Gevaert Group Net financial debt in million Euro 311 276* 255 117 115 118 140 144 99 137 194 52 55 161 40 27 22 19 18 -18 -37 * IFRS 16 impact of 115 million Euro Q1'16 Q2'16 Q3'16 Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 7
Slide 8: Working capital
Agfa-Gevaert Group Working capital in million Euro Q4 2018 Q3 2019 in million Euro Inventories 498 512 DIOH (in days) 117 120 Trade Receivables, Contract Assets, 374 349 Contract liabilities DSO (in days) 56 57 Trade Payables (219) (227) DPO (in days) 52 53 Trade Working Capital 653 633 as a % of sa
Slide 9: Corporate Services
Corporate Services Q3 ’19 Q3 ’18 ∆% 9m’19 9m’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Adjusted EBITDA* -3.7** -3.7 0.9% -12.1 -10.9 10.4% Adjusted EBIT* -3.7** -3.7 -0.9% -12.9 -10.9
Slide 10: Offset Solutions
| \ ‘ \ Offset Solutions '
Slide 11: Offset Solutions sales by business segment
Offset Solutions Sales 9m 2019 = 617 million Euro by business segment 13% Digital computer-to-plate Analog computer-to-film 87% 11
Slide 12: Offset Solutions key figures
Offset Solutions Q3 ’19 Q3 ’18 ∆% 9m’19 9m’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 212 204 3.6% 617 632 -2.2% (1.9%) (-4.0%) Gross Profit* 44 50 -12.6% 144 166 -13.1% as a % of
Slide 13: Offset Solutions main drivers
Offset Solutions As the alliance with Lucky is coming up to speed, the Offset Solutions division was able to post a 3.6% top line growth (1.9% Main drivers behind excluding currency effects) compared to the third quarter of 2018. key figures It is expected that the effects of the alliance will bec
Slide 14: Digital Print & Chemicals
Digital Print & Chemicals
Slide 15: Digital Print & Chemicals sales by business segment
Digital Print & Chemicals Sales 9m 2019 = 294 million Euro by business segment 39% Inkjet 47% Electronic Print Films and Foils 14% 15
Slide 16: Digital Print & Chemicals key figures
Digital Print & Chemicals Q3 ’19 Q3 ’18 ∆% 9m’1 9m’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) 9 IFRS(excl. 16, (excl.curr.) in million Euro (excl. restated) restated) Profit & Loss IFRS 16) Sales 85 98 -13.0% 294 292 0.6% (-14.0%) (-1.3%) Gross Profit* 23 27 -14.0% 84 79 7.1% as
Slide 17: Digital Print & Chemicals main drivers
Digital Print & Chemicals Mainly as a result of the discontinuation of the reseller Main drivers behind activities related to inkjet media in the USA, the top line of the Digital Print & Chemicals division decreased by 13.0% key figures (14.0% excluding currency effects) compared to the third quar
Slide 18: Radiology Solutions
Radiology Solutions
Slide 19: Radiology Solutions sales by business segment
Radiology Solutions Sales 9m 2019 = 383 million Euro by business segment 6% Hardcopy 36% CR/DR 58% Classic Radiology 19
Slide 20: Radiology Solutions key figures
Radiology Solutions Q3 ’19 Q3 ’18 ∆% 9m’19 9m’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 132 118 11.8% 383 364 5.2% (9.8%) (4.7%) Gross Profit* 46 42 9.0% 140 127 9.9% as a % of s
Slide 21: Radiology Solutions main drivers
Radiology Solutions Main drivers behind The Radiology Solutions division’s revenue increased by 11.8% compared to the third quarter of 2018 based on key figures double-digit growth for both the hardcopy business and the Direct Radiography solutions range. The hardcopy business continued to benefit
Slide 22: HealthCare IT
HealthCare IT
Slide 23: HealthCare IT sales by business segment
HealthCare IT Sales by business 9m 2019 = 374 million Euro segment 40% HCIS Imaging IT Solutions 60% 23
Slide 24: HealthCare IT key figures
HealthCare IT Q3 ’19 Q3 ’18 ∆% 9m’19 9m’18 ∆% Key figures (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) (excl. IFRS 16) (excl. IFRS 16, (excl.curr.) in million Euro restated) restated) Profit & Loss Sales 125 119 5.0% 374 360 3.9% (3.7%) (2.3%) Gross Profit* 59 52 11.8% 173 157 10.1% as a % of sales
Slide 25: HealthCare IT main drivers
HealthCare IT Main drivers behind The HealthCare IT division posted substantial top line growth, key figures based on the good performance of the HealthCare Information Solutions business especially. Like in the previous quarters, the HealthCare Information Solutions business again recorded solid
Slide 26: Questions & Answers
Questions & Answers AGFA &